QGEN
Qiagen NV
NYSE: QGEN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$33.61
-1.21% today
Updated 2026-04-29
Market cap
$6.93B
P/E ratio
16.48
P/S ratio
3.31x
EPS (TTM)
$2.04
Dividend yield
0.77%
52W range
$33 – $58
Volume
1.9M
Qiagen NV (QGEN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $765.30M | $1.21B | $2.78B | $2.89B | $3.80B | $3.91B | $3.76B | $4.13B | $4.09B | $4.45B | $4.19B | $4.31B | $5.04B | $5.75B | $5.24B | $5.87B | $6.15B | $6.29B | $6.12B | $5.69B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $370.26M | $683.19M | $647.95M | $703.55M | $1.33B | $1.36B | $748.43M | $992.62M | $920.89M | $1.10B | $961.61M | $1.04B | $1.65B | $2.16B | $1.57B | $1.62B | $2.11B | $2.39B | $2.15B | $1.96B |
| Total liabilities | $314.84M | $645.85M | $1.38B | $1.43B | $1.51B | $1.44B | $1.20B | $1.40B | $1.36B | $1.80B | $1.63B | $1.70B | $2.50B | $3.11B | $2.70B | $3.07B | $3.05B | $2.82B | $2.31B | $2.12B |
| Current liabilities | $91.67M | $116.53M | $165.73M | $262.38M | $375.53M | $388.41M | $481.66M | $300.38M | $337.04M | $431.63M | $268.35M | $308.43M | $324.79M | $972.19M | $951.35M | $572.17M | $1.52B | $974.52M | $1.08B | $543.63M |
| Long-term debt | $202.55M | $501.60M | $983.02M | $951.11M | $898.95M | $820.53M | $446.00M | $861.73M | $856.85M | $1.04B | $1.05B | $1.07B | $1.76B | $1.67B | $1.42B | $1.88B | $1.09B | $1.47B | $921.82M | $1.34B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $274.20M | $344.74M | $388.78M | $477.81M | $615.58M | $759.89M | $855.93M | $985.43M | $1.05B | $929.35M | $1.23B | $929.63M | $1.03B | $1.38B | $1.18B | $1.32B | $1.79B | $2.16B | $2.46B | $2.45B |
| Accounts receivable | $71.98M | $87.58M | $152.54M | $179.32M | $237.33M | $248.67M | $273.98M | $307.37M | $334.37M | $309.98M | $325.89M | $302.04M | $368.65M | $397.68M | $484.61M | $486.61M | $469.66M | $434.07M | $515.64M | $458.98M |
| Inventory | $53.65M | $64.08M | $88.35M | $108.56M | $130.85M | $126.63M | $132.24M | $135.29M | $128.10M | $132.28M | $136.59M | $136.55M | $155.93M | $162.91M | $170.70M | $291.18M | $327.52M | $357.96M | $398.38M | $279.26M |
| Goodwill | $93.91M | $160.14M | $1.11B | $1.15B | $1.34B | $1.35B | $1.73B | $1.76B | $1.86B | $1.89B | $1.88B | $1.93B | $2.01B | $2.11B | $2.14B | $2.36B | $2.35B | $2.35B | $2.48B | $2.43B |